Home › Siemens Healthineers to Invest $300M to Expand Dx Manufacturing, R&D in Massachusetts

Siemens Healthineers to Invest $300M to Expand Dx Manufacturing, R&D in Massachusetts

Dec 14, 2016

NEW YORK (GenomeWeb) – Siemens Healthineers said today that it will invest $300 million to expand and upgrade its 500,000-sq. ft. laboratory diagnostics manufacturing and R&D facility in Walpole, Massachusetts, over the next four years.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Featured Webinar

A Long-Read vs. Short-Read Platform Comparison: Best NGS Approaches for Microbiome Studies

Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Jan
30
Featured Webinar

A Long-Read vs. Short-Read Platform Comparison: Best NGS approaches for Microbiome Studies

Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

What's Popular?

In Infectious Disease

  1. Mobidiag, Autobio Diagnostics to Form Joint Venture in China

  2. Curetis to Cut 30 Percent of Workforce as Part of Strategic Restructuring

  3. HiberGene Gets CE Mark for Rapid Flu Combo MDx

  4. ChromaCode Tackling Tick-Borne Illness Testing With Multiplex Molecular Panel

    Premium

  5. Atomo Diagnostics Wins Australian Approval for HIV Self-Test

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.